MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - The Molina Healthcare class action lawsuit alleges that the company and its executives failed to disclose significant adverse information regarding its financial health and operational challenges during the specified class period, leading to substantial losses for investors [4][5][6]. Group 1: Class Action Details - The class action lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and covers purchasers of Molina Healthcare securities from February 5, 2025, to July 23, 2025 [1]. - Investors have until December 2, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit claims violations of the Securities Exchange Act of 1934 by Molina Healthcare and its top executives [1]. Group 2: Allegations Against Molina Healthcare - The lawsuit alleges that Molina Healthcare failed to disclose material adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. - It is claimed that Molina's near-term growth relied on reduced utilization of behavioral health, pharmacy, and inpatient and outpatient services [4]. - The lawsuit asserts that Molina's financial guidance for fiscal year 2025 was likely to be cut due to these undisclosed issues [4]. Group 3: Financial Impact and Stock Performance - On July 7, 2025, Molina reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [5]. - Following this announcement, Molina's stock price fell significantly, reflecting investor concerns over the company's financial outlook [5]. - On July 23, 2025, Molina further cut its full-year 2025 earnings guidance, reporting a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year [6]. - The stock price reportedly dropped nearly 17% after this news, indicating a strong negative market reaction [6]. Group 4: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Molina securities during the class period to seek lead plaintiff status [7]. - The lead plaintiff will represent the interests of all class members and can select a law firm for litigation [7]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [8].